Lastly, depletion of myeloid IKKβ resulted in enhanced late long-term potentiation in EAE, suggesting that brain cognitive abilities may be affected by the use of non-specific therapeutic interventions that inhibit NF-κB activity in MS, which needs to be taken under consideration. The gene discussed is NFKB1; the disease is myeloid sarcoma.